Enveda (Series E)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
September 27, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$311,000,000
Company Info
Traction
The round follows two positive early clinical readouts in 2026, enabling the company to advance multiple programs through the clinic.
Founders
George Petrocheilos
Market
Clinical-stage biotechnology
Location
Boulder, Colorado, USA
Coinvestors
Durable Capital Partners, ICONIQ, Lightspeed, Surveyor Capital, T. Rowe Price Investment Management, Digitalis Ventures, Sovereign Wealth Fund, Alderline Group, Baillie Gifford, Premji Invest, FPV Ventures, True Ventures, Kinnevik, Dimension, Lifeforce Capital, Lux Capital
Company Description

Enveda is a clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry.

Links
Website
Back to HomeBack to Biotechnology DealsView Funding Announcement